Collaboration of breast cancer clinic and genetic counseling division for BRCA1 and BRCA2 mutation family in Japan.

@article{Takeda2004CollaborationOB,
  title={Collaboration of breast cancer clinic and genetic counseling division for BRCA1 and BRCA2 mutation family in Japan.},
  author={Motohiro Takeda and Takanori Ishida and Kohji Ohnuki and Akihiko Suzuki and Masato Sakayori and Chikashi Ishioka and Tadashi Nomizu and Shinzaburou Noguchi and Yoichi Matsubara and Noriaki Ohuchi},
  journal={Breast cancer},
  year={2004},
  volume={11 1},
  pages={
          30-2
        }
}
BACKGROUND BRCA1 and BRCA2 mutations cause high breast cancer incidence rates as high as 80% Although prophylactic therapy is still controversial, several prophylactic therapies have been proposed and tried for BRCA1 and BRCA2 mutation carriers. Prophylactic surgery, chemo-prevention and precise screening have been proposed as prophylactic therapy. All BRCA1 and BRCA2 mutation carriers need knowledge about their disease and the countermeasures that are used to protect against onset of disease… CONTINUE READING
BETA

Similar Papers

Loading similar papers…